These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lentinacin: a new hypocholesterolemic substance in Lentinus edodes. Chibata I; Okumura K; Takeyama S; Kotera K Experientia; 1969 Dec; 25(12):1237-8. PubMed ID: 5391883 [No Abstract] [Full Text] [Related]
23. Hypocholesterolemic agents. 10. Synthesis of some model azacholanic acids as potential regulators of steroid biosynthesis and metabolism. Venton DL; Kohen F; Counsell RE J Med Chem; 1973 May; 16(5):571-3. PubMed ID: 4718479 [No Abstract] [Full Text] [Related]
24. Certain disubstituted o-aminoacetoxy- and propoxybenzoic and cinnamic acids and their tert-butyl esters. Gringauz A J Pharm Sci; 1970 Mar; 59(3):422-5. PubMed ID: 5416196 [No Abstract] [Full Text] [Related]
25. Novel enzymatic synthesis of 4-O-cinnamoyl quinic and shikimic acid derivatives. Armesto N; Ferrero M; Fernández S; Gotor V J Org Chem; 2003 Jul; 68(14):5784-7. PubMed ID: 12839485 [TBL] [Abstract][Full Text] [Related]
26. Interaction of bile acids and cholesterol with non-systemic agents having hypocholesterolemic properties. Stedronsky ER Biochim Biophys Acta; 1994 Jan; 1210(3):255-87. PubMed ID: 8305482 [No Abstract] [Full Text] [Related]
27. [New N1-acyl-N4-arylthiosemicarbazides with therapeutic action. 3. Phenylthiosemicarbazides of alpha-(para-acetylaminophenylamide)-cinnamic acid with spasmolytic effect]. Demetrescu C; Manu V; Chirită C Pharmazie; 1970; 25(5):317-9. PubMed ID: 5455410 [No Abstract] [Full Text] [Related]
28. [Synthesis of 3-amino-4-methyl-2-pentenamide, 2-amino-1-cyclohexene-1-carboxamide and 3-amino-2,4-diphenyl-2-butenamide and synthesis of 4(3H)-pyrimidone derivatives from them]. Kato T; Yamanaka H; Konno S Yakugaku Zasshi; 1971 Sep; 91(9):1004-12. PubMed ID: 5167044 [No Abstract] [Full Text] [Related]
32. Cycloalkanones. 8. Hypocholesterolemic activity of long-chain ketones related to pentadecanone. Wyrick SD; Hall IH; Piantadosi C; Fenske CR J Med Chem; 1976 Feb; 19(2):219-22. PubMed ID: 1249802 [TBL] [Abstract][Full Text] [Related]
33. [Effect of cynarin on fatty liver]. Eberhardt G Z Gastroenterol; 1973 Apr; 11(3):183-6. PubMed ID: 4803418 [No Abstract] [Full Text] [Related]
34. Cycloalkanones. 3. Structure-activity relationships of hypocholesterolemic cyclooctanone derivatives. Carlson GL; Hall IH; Abernethy GS; Piantadosi C J Med Chem; 1974 Feb; 17(2):154-7. PubMed ID: 4809249 [No Abstract] [Full Text] [Related]
35. 2,4,5-trimethoxycinnamic acid: the major metabolite of alpha-asarone, retains most of the pharmacological properties of alpha-asarone. Antunez-Solis J; Hernández-Derramadero F; Aquino-Vega M; Ibarra-Ramírez S; Rodríguez-Páez L; Baeza I; Wong C J Enzyme Inhib Med Chem; 2009 Jun; 24(3):903-9. PubMed ID: 18686138 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and hypocholesterolemic activity of 6,7-dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, novel inhibitors of acylCoA:cholesterol O-acyltransferase. Larsen SD; Spilman CH; Bell FP; Dinh DM; Martinborough E; Wilson GJ J Med Chem; 1991 May; 34(5):1721-7. PubMed ID: 2033594 [TBL] [Abstract][Full Text] [Related]
37. Biological evaluation in vivo and in vitro of selected 5-alpha-cholestane-3-beta, 5-alpha, 6-beta-triol analogs as hypocholesterolemic agents. Witiak DT; Parker RA; Brann DR; Dempsey ME; Ritter MC; Connor WE; Brahmankar DM J Med Chem; 1971 Mar; 14(3):216-22. PubMed ID: 5552212 [No Abstract] [Full Text] [Related]